|
NSJ Bioreagents
cd5 antibody Cd5 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd5 antibody/product/NSJ Bioreagents Average 94 stars, based on 1 article reviews
cd5 antibody - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd5 antibody, anti-mouse, reafinity Cd5 Antibody, Anti Mouse, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd5 antibody, anti-mouse, reafinity/product/Miltenyi Biotec Average 93 stars, based on 1 article reviews
cd5 antibody, anti-mouse, reafinity - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
anti cd5 percp vio700 Anti Cd5 Percp Vio700, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti cd5 percp vio700/product/Miltenyi Biotec Average 94 stars, based on 1 article reviews
anti cd5 percp vio700 - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
Sino Biological
lnp mcd5 Lnp Mcd5, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/lnp mcd5/product/Sino Biological Average 93 stars, based on 1 article reviews
lnp mcd5 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Thermo Fisher
cd5 fitc Cd5 Fitc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd5 fitc/product/Thermo Fisher Average 94 stars, based on 1 article reviews
cd5 fitc - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
cd2 cd3 cd5 cd7 pan t cells ![]() Cd2 Cd3 Cd5 Cd7 Pan T Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd2 cd3 cd5 cd7 pan t cells/product/Miltenyi Biotec Average 99 stars, based on 1 article reviews
cd2 cd3 cd5 cd7 pan t cells - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
|
Bio-Rad
cd5 ![]() Cd5, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd5/product/Bio-Rad Average 93 stars, based on 1 article reviews
cd5 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Miltenyi Biotec
через 24 ч к активированным т лимфоцитам добавляли ретровирусный анти cd5 вектор и реагент vectofusin 1 ![]() через 24 ч к активированным т лимфоцитам добавляли ретровирусный анти Cd5 вектор и реагент Vectofusin 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/через 24 ч к активированным т лимфоцитам добавляли ретровирусный анти cd5 вектор и реагент vectofusin 1/product/Miltenyi Biotec Average 97 stars, based on 1 article reviews
через 24 ч к активированным т лимфоцитам добавляли ретровирусный анти cd5 вектор и реагент vectofusin 1 - by Bioz Stars,
2026-03
97/100 stars
|
Buy from Supplier |
Journal: Clinical and Translational Medicine
Article Title: Granulocyte colony‐stimulating factor induced T‐cell hyporesponsiveness via modulation of CD177 + S100A hi neutrophils in unexplained recurrent pregnancy loss
doi: 10.1002/ctm2.70508
Figure Lengend Snippet: Immunosuppressive capacity of circulating CD177 + S100A hi neutrophils. (A) Schematic representation of T cells and neutrophils co‐culture system. CD3/CD28‐primed pan‐T cells from healthy donors were co‐cultured in the absence or presence of CD177 + S100A hi neutrophils from G‐PB of early pregnancy. (B and C) Representative images of proliferative alterations (B, left), proportion of proliferative CD4 + T cells (B, right top) and CD8 + T cells (B, right bottom), secretion of TNF‐α (C, top) and IFN‐γ (C, bottom) in co‐cultures of pan‐T cells with or without CD177 + S100A hi ‐LDNs and CD177 + S100A hi ‐NDNs (ratio of 1:5) at Day 3.5 ( n = 7). Data are represented as mean ± SD. The symbol ‘–’ indicates T cells without CD3/CD28 stimulation, whereas ‘+’ designates T cells primed with CD3/CD28. (D) Boxplot showing proportion of proliferative CD4 + T cells (left) and CD8 + T cells (right) in co‐cultures of pan‐T cells with CD177 + S100A hi ‐LDNs and CD177 + S100A hi ‐NDNs (ratio of 1:5) under a Transwell device at Day 3.5 ( n = 3). Data are represented as mean ± SD. (E) Quantification of apoptosis of CD4 + T cells and CD8 + T cells at a co‐culture ratio of 1:5 ( n = 4). Data are represented as mean ± SEM. (F) Enriched GO terms for the downregulated proteins in T cells from co‐cultures of pan‐T cells with CD177 + S100A hi ‐LDNs. The thickness of the string is proportional to LogFC. (G) Violin plot of average expression of co‐inhibitory receptor molecules TIGIT, TIM‐3, LAG‐3 and PSGL‐1 in T cells exposed to CD177 + S100A hi ‐LDNs compared with cultured alone. The y ‐axis represents the value of the log2 protein abundance. (H) L‐Arg concentration in supernatant from co‐cultures of pan‐T cells with or without CD177 + S100A hi ‐LDNs and CD177 + S100A hi ‐NDNs (ratio of 1:5) at Day 3.5 ( n = 7). Data are represented as mean ± SD. (I and J) The proportion of proliferative CD4 + T cells (left) and CD8 + T cells (right) in co‐cultures of pan‐T cells with or without CD177 + S100A hi ‐LDNs and CD177 + S100A hi ‐NDNs (ratio of 1:5), with or without: 200 µg/mL L‐Arg (I); 200 U/mL CAT (J, top); 2 mM NAC (J, bottom). Data are represented as mean ± SD. p ‐values are calculated using the one‐way ANOVA with Tukey's post hoc test and Student's t ‐test. G‐PB, G‐CSF‐mobilised peripheral blood; LDNs, low density neutrophils; NDNs, normal density neutrophils; TNF‐α, tumour necrosis factor‐α; IFN‐γ, interferon‐γ; ARG1, arginase 1; ROS, reactive oxygen species; L‐Arg, L‐arginine; CAT, catalase.
Article Snippet:
Techniques: Co-Culture Assay, Cell Culture, Expressing, Quantitative Proteomics, Concentration Assay
Journal: Clinical and Translational Medicine
Article Title: Granulocyte colony‐stimulating factor induced T‐cell hyporesponsiveness via modulation of CD177 + S100A hi neutrophils in unexplained recurrent pregnancy loss
doi: 10.1002/ctm2.70508
Figure Lengend Snippet: Diminished CD177 + S100A hi neutrophils in PB of URPL. (A) Representative flow cytometry plots showing distribution of neutrophils in PBMCs and NDNs layers of HCs, patients with URPL and URPL receiving G‐CSF treatment. NDNs and LDNs are gated based on CD45 and side‐scatter properties in PBMCs and NDNs fractions, respectively. Reliable neutrophils are identified as CD15 + cells among NDNs/LDNs. (B) Representative flow cytometry plots and quantification showing percentage of CD177 + S100A hi ‐LDNs in HCs and URPL patients receiving G‐CSF treatment ( n = 8/each group). Data are represented as mean ± SD. (C) Representative flow cytometry plots and quantification showing percentage of CD177 + S100A hi ‐NDNs in HCs ( n = 8), patients with URPL ( n = 6) and URPL receiving G‐CSF treatment ( n = 8). Data are represented as mean ± SD. (D) Flow cytometry of ARG1 expression in HC, patients with URPL and URPL receiving G‐CSF treatment ( n = 5/each group). Data are represented as mean ± SD. (E) Serum L‐Arg concentrations in HCs ( n = 13), patients with URPL ( n = 18) and URPL receiving G‐CSF treatment ( n = 18). Data are represented as mean ± SD. (F) The percentage of circulating neutrophils detected in PB before and after G‐CSF administration ( n = 16/each group). (G) Relative mRNA expression of CD177, S100A8, S100A9 and S100A12 between G‐CSF‐mobilised and non‐mobilised neutrophils ( n = 16/each group). (H) The percentage of circulating CD3 + T cells detected in PBMCs before and after G‐CSF administration ( n = 8/each group). (I) Expression of inflammation‐related factors TNF‐α, IFN‐γ, IL‐6 and IL‐1β in pregnant women with URPL history before and after G‐CSF administration ( n = 13/each group). p ‐values are calculated using the one‐way ANOVA with Tukey's post hoc test and Student's t ‐test. PBMCs, peripheral blood mononuclear cells; HCs, healthy pregnant controls; URPL, unexplained recurrent pregnancy loss; LDNs, low density neutrophils; NDNs, normal density neutrophils; ARG1, arginase 1; MFI, mean fluorescence intensity; L‐Arg, L‐arginine; TNF‐α, tumour necrosis factor‐α; IFN‐γ, interferon‐γ; IL‐6, interleukin‐6.
Article Snippet:
Techniques: Flow Cytometry, Expressing, Fluorescence